| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7da5c8e8c3e8261efe7e698c7198681b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-11 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-747
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-245 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-747
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 |
| filingDate |
2015-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8928665757ce28907d9171b4bda57b12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d7958468aaaf5819c4ed1bb4aa3a975
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_224307e5ac8a80073f480e4c88506341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcdaaeba7b1a85cac03b023a8e2aa2cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ee4b530dab51cd090b199628e8d1031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96c0497accf46982962a6358b1f84ee8 |
| publicationDate |
2015-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015177366-A1 |
| titleOfInvention |
New strain of lactobacillus casei with ability to degrade the immunotoxic peptide from gluten |
| abstract |
The invention relates to a bacterial strain, Lactobacillus casei IPLA12038 with deposit number CECT 8590, and its use for the degradation of gluten, gliadin or derivative peptides. The strain has been isolated from an acidic dough used to make bread. Its advantages include the ability to use gliadin as nitrogen source, possess peptidase activities involved in the degradation of it and be able to completely degrade the immunotoxic (33) amino acid peptide involved in triggering of celiac disease in a short period of time. The fact of considering it a GRAS and QPS microorganism, isolated from a fermented food, sensitive to antimicrobial gastrointestinal agents and resistant to gastrointestinal conditions tested in vitro , guarantees its use as a probiotic or nutraceutical supplement. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110622005-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021129997-A1 |
| priorityDate |
2014-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |